Form 4: Zivo Bioscience Director Maggiore Reports Acquisition of Shares
SEC Form 4 Filing
Director Christopher D. Maggiore reports acquiring shares of Zivo Bioscience, Inc. on January 1, 2025.
Summary
- On January 1, 2025, Christopher D. Maggiore, a director of Zivo Bioscience, Inc., acquired 1,300 shares of common stock at $0, increasing his holdings to 499,743 shares.
- Maggiore also acquired 7,277 shares of common stock at $0 on the same date, bringing his total holdings to 507,020 shares.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing, so the sentiment is neither positive nor negative.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for insiders of publicly traded companies, providing transparency into their trading activities.
Stakeholder Impact
- Shareholders are informed about the trading activities of a company director.
Key Dates
| Date | Description |
|---|---|
| 01/01/2025 | Date of common stock acquisition |
| 01/03/2025 | Date of signature on the report |
Keywords
Zivo Bioscience, Maggiore, Director, Share Acquisition, Form 4, Beneficial Ownership, ZIVO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.